Article

Metastatic Breast Cancer Awareness Day: What You Need to Know

For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space.

For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space:

  1. Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE to discuss her experiences with non-Hodgkin lymphoma, then stage 2 breast cancer and, most recently, metastatic stage 4 breast cancer.
  2. After being diagnosed with metastatic breast cancer in January 2015, CURE contributor Martha Carlson shares some tips on how to responsibly search for healthcare information online.
  3. The Food and Drug Administration recently approved Piqray (alpelisib) for the treatment of certain postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer.
  4. Eight-year metastatic “thriver” Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.
  5. In another FDA action, the subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy was approved for the treatment of select patients with breast cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.